CTS Spotlight at 2018 AABB Annual Meeting
Sunday, October 14, 2018 at 1:30 PM: Scientific Oral Abstract Plenary Session (BBC57) Multicenter Clinical Evaluation of a Babesia Transcription-Mediated Amplification Assay on a Fully Automated System Phillip C. Williamson, Ph.D.
Monday, October 15, 2018 at 2:30PM: (BBC2-MN3-24) Recently Acquired Hepatitis C Infections in US Blood Donors: Genotype and Geographic Distribution of NAT Yield Blood Donations across the Continental US Valerie Winkelman and Phillip C. Williamson, Ph.D.
Tuesday, October 16, 2018 at 11:45AM a: (PHP2 - TU3-23) Characteristics of HIV Infections, Including Genotypes and Drug Resistance Mutations, in Blood Donors in the US Phillip C. Williamson, Ph.D.
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...